KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Shares Sold by Emerald Advisers LLC

Emerald Advisers LLC reduced its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 4.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 643,897 shares of the specialty pharmaceutical company’s stock after selling 27,279 shares during the quarter. Emerald Advisers LLC owned […]

Leave a Reply

Your email address will not be published.

Previous post Kinross Gold Co. (NYSE:KGC) Position Raised by Triasima Portfolio Management inc.
Next post MRA Advisory Group Decreases Stake in Walmart Inc. (NYSE:WMT)